Skip to content
No results
  • About Us
  • Contact Us
  • Disclaimer
  • Event Venues
  • Events and Conferences
  • Home
  • Organizer Dashboard
  • Organizer Dashboard
  • Privacy Policy
  • Submit Organizer Form
  • Submit Organizer Form
  • Submit Venue Form
  • Submit Venue Form
  • Subscribe
  • Terms and Conditions
  • Venue Dashboard
  • Venue Dashboard
  • About Us
  • Contact Us
The Pharma Data

  • News
  • Press Releases
  • Research
  • Business
  • Regulatory
  • Events and Conferences
The Pharma Data
  • Regulatory

Brenus Pharma Takes Home French Tech Saint-Etienne Lyon’s Prestigious Start-up of the Year Prize

  • The Pharma Data
  • July 4, 2024

During its annual event “BIG UP,” French Tech Saint-Etienne Lyon awarded the prestigious BIG Start-up of the Year trophy, recognizing a start-up that embodies innovation and vitality within the region.…

Read MoreBrenus Pharma Takes Home French Tech Saint-Etienne Lyon’s Prestigious Start-up of the Year Prize
  • News

32 Athletes from Bayer Sports Clubs Head to the Summer Games in Paris

  • The Pharma Data
  • July 2, 2024

Exactly 120 years after the establishment of “Turn- und Spielverein der Farbenfabriken vorm. Friedr. Bayer & Co.”, the first Bayer sports club in Germany, Bill Anderson, CEO of Bayer AG,…

Read More32 Athletes from Bayer Sports Clubs Head to the Summer Games in Paris
  • News

EU CHMP Recommends Lynparza and Imfinzi Combo for Advanced/Recurrent Endometrial Cancer

  • The Pharma Data
  • July 2, 2024

AstraZeneca’s Imfinzi (durvalumab) and Lynparza (olaparib) have been recommended for approval in the European Union (EU) for patients with primary advanced or recurrent endometrial cancer. The combination of Imfinzi plus…

Read MoreEU CHMP Recommends Lynparza and Imfinzi Combo for Advanced/Recurrent Endometrial Cancer
  • Business

Sipavibart EMA Regulatory Submission Approved for Accelerated Assessment in COVID-19 Prevention

  • The Pharma Data
  • July 2, 2024

AstraZeneca’s Marketing Authorisation Application (MAA) for sipavibart has been accepted under the accelerated assessment procedure by the European Medicines Agency (EMA) for the pre-exposure prophylaxis (prevention) of COVID-19 in immunocompromised…

Read MoreSipavibart EMA Regulatory Submission Approved for Accelerated Assessment in COVID-19 Prevention
  • Business

Robert A. Michael Appointed as CEO of AbbVie

  • The Pharma Data
  • July 2, 2024

AbbVie announced today that Robert A. Michael has taken on the role of Chief Executive Officer (CEO) and joined the company’s Board of Directors, effective immediately. As previously announced, Mr.…

Read MoreRobert A. Michael Appointed as CEO of AbbVie
  • News

Merck Secures Global Rights to Opevesostat for Prostate Cancer

  • The Pharma Data
  • July 2, 2024

MSD (known as Merck & Co., Inc. in the US and Canada) and Orion Corporation announced the mutual exercise of an option to convert their co-development and co-commercialization agreement for…

Read MoreMerck Secures Global Rights to Opevesostat for Prostate Cancer
  • Press Releases

Merck Announces Second-Quarter 2024 Sales and Earnings Conference Call on July 30

  • The Pharma Data
  • July 2, 2024

MSD, known as Merck outside the United States and Canada, will host its second-quarter 2024 sales and earnings conference call for institutional investors and analysts at 9:00 a.m. ET on…

Read MoreMerck Announces Second-Quarter 2024 Sales and Earnings Conference Call on July 30
  • Press Releases

UCB Showcases Latest Insights on Newly Launched gMG Portfolio at EAN Congress

  • The Pharma Data
  • June 29, 2024

UCB, a global biopharmaceutical company, has unveiled new research findings supporting its recently launched treatments in the generalized myasthenia gravis (gMG) portfolio. These findings will be presented at the 10th…

Read MoreUCB Showcases Latest Insights on Newly Launched gMG Portfolio at EAN Congress
  • News

Pfizer, BioNTech Get CHMP Nod for Omicron JN.1-adapted COVID-19 Vaccine in EU

  • The Pharma Data
  • June 29, 2024

Sure, here’s a rewritten version of the article: Today, Pfizer and BioNTech announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has…

Read MorePfizer, BioNTech Get CHMP Nod for Omicron JN.1-adapted COVID-19 Vaccine in EU
  • Research

LEQEMBI® (Lecanemab) Launches in China for Alzheimer’s Disease Treatment

  • The Pharma Data
  • June 29, 2024

Biogen, headquartered in Cambridge, Massachusetts, and led by CEO Christopher A. Viehbacher, announced today the launch of “LEQEMBI®” (known as “乐意保®” in China), a humanized anti-soluble aggregated amyloid-beta (Aβ) monoclonal…

Read MoreLEQEMBI® (Lecanemab) Launches in China for Alzheimer’s Disease Treatment
  • Regulatory

Frexalimab Phase 2 Results: Reduction of Key Biomarker of Nerve Cell Damage in Relapsing MS

  • The Pharma Data
  • June 29, 2024

Sanofi’s CD40L monoclonal antibody, frexalimab, has demonstrated promising results in reducing a key biomarker associated with nerve cell damage in patients with relapsing multiple sclerosis (MS), suggesting potential benefits in…

Read MoreFrexalimab Phase 2 Results: Reduction of Key Biomarker of Nerve Cell Damage in Relapsing MS
  • Research

Pfizer and BioNTech Granted Favorable CHMP Opinion for Omicron JN.1-adapted COVID-19 Vaccine in the European Union

  • The Pharma Data
  • June 29, 2024

Today, Pfizer and BioNTech announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended the approval of their Omicron JN.1-adapted monovalent…

Read MorePfizer and BioNTech Granted Favorable CHMP Opinion for Omicron JN.1-adapted COVID-19 Vaccine in the European Union
PrevNext
UK Biotech Day
Global Clinical Trial Supply Forum 2026 I Frankfurt, Germany
Global Clinical

About

The Pharma Data is an Information-Centric Website focused mainly on the Pharmaceutical Industry Online It is a B2B Platform mainly focused on the latest Pharmaceutical News, Press releases, Industry-related updates, Events, and Conferences. With The Pharma Data, you can get all the information that happening in the Pharmaceutical industry.

Advertise With Us: marketing@thepharmadata.com

Latest Posts

  • WuXi Biologics Secures CDMO Leadership Awards for Ninth Straight Year
  • Kerendia™ Receives EU Approval for New Indication in Adults with Heart Failure and LVEF ≥40%
  • FDA Clears High-Dose SPINRAZA® (Nusinersen) Regimen for Spinal Muscular Atrophy
  • About Us
  • Disclaimer
  • Privacy Policy
  • Terms and Conditions
  • Contact Us

Copyright © 2026 | The Pharma Data | Marnet Technologies Pvt Ltd | All Rights Reserved.